Jul 29, 2024
Varian Announces Future-Focused, Integrated Microwave Ablation Ecosystem with IntelliBlate
Jul 22, 2024
Varian Announces Powerful Functionality, Expanding Versatility and Connectivity for its Ethos Adaptive Radiotherapy System
May 15, 2024
Varian Announces Exclusive US Distribution Agreement with Innova Vascular for New Innovative Thrombectomy Solutions
May 02, 2024
Together with Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024
May 02, 2024
Together with Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024
Feb 29, 2024
Varian Receives FDA 510(k) Clearance for TrueBeam and Edge Radiotherapy Systems Featuring HyperSight Imaging Solution
Jan 04, 2024
Varian and Nova Scotia Health Form First Multi-Disciplinary Oncology Partnership to Catalyze Advancements in Cancer Care
Feb 04, 2021
Varian Installs World's First ProBeam® 360° Proton Therapy System at Penn Medicine Lancaster General Health
Jan 26, 2021
Varian Reports Results for First Quarter of Fiscal Year 2021
Jan 08, 2021
Varian Announces First Quarter Fiscal Year 2021 Earnings Release Date
Oct 20, 2020
Varian Congratulates Historic Trade Package Agreement with Brazil
Oct 19, 2020
Varian Announces Presence at American Society for Radiation Oncology (ASTRO) Annual Meeting Highlighting Advancements in Intelligent Cancer Care(TM)
Sep 16, 2020
Varian Expects to Benefit from the Extension of Medical Linear Accelerators Tariff Exclusion in China
Sep 15, 2020
Varian Drives Next Evolution of Proton Treatment Planning with Eclipse v16.1
Sep 09, 2020
Germany's first Ethos Therapy Ordered by the German Cancer Research Center
Aug 02, 2020
Varian Reports Results for Third Quarter of Fiscal Year 2020
Aug 02, 2020
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
Jul 17, 2020
Varian Announces Third Quarter Fiscal Year 2020 Earnings Release Date
Jul 06, 2020
Varian Wins "Best After-Sales Service Award for Radiotherapy Products" in China For Third Year In A Row
Jun 25, 2020
Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers